PASSAGE BILIARY DILATATION CATHETER 5021

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 1999-09-01 for PASSAGE BILIARY DILATATION CATHETER 5021 manufactured by Microvasive Endoscopy A Div Of Boston Scientific Corp..

Event Text Entries

[137296] In was reported on 12/28/1998, that during an endoscopic retrograde cholangio-pancreatography procedure, the physician stated that he could not see the radiopaque markers on a passage dilator catheter and he subsequently perforated the pts' bile duct. A temporary stent was placed as intervention. No product was returned for eval.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000048-1999-00014
MDR Report Key239517
Report Source05,06
Date Received1999-09-01
Date of Report1999-09-01
Date of Event1998-12-21
Device Manufacturer Date1998-07-01
Date Added to Maude1999-09-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePASSAGE BILIARY DILATATION CATHETER
Generic NameDILATATION CATHETER
Product CodeGCC
Date Received1999-09-01
Model NumberNA
Catalog Number5021
Lot Number1699962
ID NumberNA
Device Expiration Date2001-02-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key232087
ManufacturerMICROVASIVE ENDOSCOPY A DIV OF BOSTON SCIENTIFIC CORP.
Manufacturer Address780 BROOKSIDE DRIVE SPENCER IN 47460 US
Baseline Brand NamePASSAGE BILIARY DILATATION CATHETER
Baseline Generic NameDILATATION CATHETER
Baseline Catalog No5021
Baseline Device FamilyDILATATION CATHETER
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK833417
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1999-09-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.